本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kura Oncology, Inc

10.91
-0.3000-2.68%
成交量:186.04万
成交额:2,079.73万
市值:9.49亿
市盈率:-4.40
高:11.50
开:11.13
低:10.81
收:11.21
52周最高:16.68
52周最低:5.41
股本:8,701.75万
流通股本:6,398.56万
量比:0.75
换手率:2.91%
股息:- -
股息率:- -
每股收益(TTM):-2.4801
每股收益(LYR):-2.0193
净资产收益率:-65.10%
总资产收益率:-26.57%
市净率:3.91
市盈率(LYR):-5.40

数据加载中...

2024/12/20

重要事件披露

Form 8-K - Current report
2024/12/05

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/20

重要事件披露

Form 8-K - Current report
2024/11/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/09/17

重要事件披露

Form 8-K - Current report
2024/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/09

重要事件披露

Form 8-K - Current report
2024/06/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/02

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/02

重要事件披露

Form 8-K - Current report
2024/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]